Luca Mogna

This inventor holds 11 USPTO granted patents and 10 published patent applications, plus 5 CIPO patents and 15 EPO patents. Top assignees: Probiotical S.p.a., Probiotical North America Inc.. Active years: 2014-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luca Mogna. Retrieved from https://idiyas.com/inventor/luca-mogna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 10)

% Patents Active = 90.9

CIPO Patents = 5

EPO Patents = 15 (Patent Applications = 17)

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 47(Granted Patents)

Company Filing History:

Probiotical North America Inc.

patents

Years Active: 2014-2022

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11446340 - Probiotic bacterial strains and symbiotic composition containing the same intended for infant food (2022-09-20),

2. 11110135 - Bacterial strains belonging to the genusfor use in the treatment of hypercholesterolaemia (2021-09-07),

3. 10982184 - Bacterial strains capable of metabolizing oxalates (2021-04-20),

4. 10738274 - Multilayer microencapsulated probiotic bacteria (2020-08-11),

5. 10286017 - Probiotic bacterial strains and symbiotic composition containing the same intended for infant food (2019-05-14),

6. 9931363 - Composition comprising probiotic bacteria for use in the treatment of immune disorders (2018-04-03),

7. 9925224 - [object Object] (2018-03-27),

8. 9498503 - Composition comprising probiotic bacteria for use in the treatment of immune disorders (2016-11-22),

9. 9492377 - Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections (2016-11-15),

10. 9185927 - [object Object] (2015-11-17),

11. 8734783 - Composition comprising probiotic bacteria for use in the treatment of immune disorders (2014-05-27),

Title: Innovations of Luca Mogna in Probiotic Research

Introduction

Luca Mogna is a prominent inventor based in Novara, Italy, known for his significant contributions to the field of probiotics. With a total of 11 patents to his name, Mogna has focused on developing innovative solutions aimed at improving health through dietary supplements and infant nutrition.

Latest Patents

Mogna's latest patents include groundbreaking work on probiotic bacterial strains and symbiotic compositions intended for infant food. One of his notable inventions describes the selection of probiotic strains belonging to specific genera for use in feeding infants. Additionally, he has developed bacterial strains aimed at treating hypercholesterolemia. This invention details a food composition or supplement that combines these bacterial strains with sterols, phytosterols, stanols, glucomannan, konjac gum, prebiotic fibers, fermented red rice, and beta-glucans from various grains.

Career Highlights

Throughout his career, Luca Mogna has worked with notable companies such as Probiotical S.p.A. and Probiotical North America Inc. His work has significantly advanced the understanding and application of probiotics in health and nutrition.

Collaborations

Mogna has collaborated with esteemed colleagues, including Giovanni Mogna and Gian Paolo Strozzi, contributing to the advancement of probiotic research and its applications.

Conclusion

Luca Mogna's innovative work in the field of probiotics has led to significant advancements in health and nutrition, particularly for infants and individuals with hypercholesterolemia. His contributions continue to influence the industry and improve dietary solutions for various health challenges.

Profile summary based on public USPTO records.